Increased plasma levels of platelet activation markers, including β‐thromboglobulin, P‐selectin, CD40 ligand and soluble platelet glycoprotein V (sGPV, GP5), are observed in patients with AF as compared with controls.63 The gene discussed is GP5; the disease is atrial fibrillation.